Abstract
BackgroundContinuous vancomycin infusion (CVI) is frequently used to achieve therapeutic levels (15–25 mg/L) in patients in whom, related to their physiological characteristics (young, obese or critical patient), intermittent infusion (II)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have